Home › MERIDIAN BIOSCIENCE, INC. › MERIFLUOR Cryptosporidium/Giardia
MERIFLUOR Cryptosporidium/Giardia
MERIDIAN BIOSCIENCE, INC. · Model 250050 · UDI-DI 00840733101113
MHI
Prescription
10
510(k) clearances
2
Adverse events
6
Recalls
17
Facilities
Description
MERIFLUOR Cryptosporidium/Giardia (MERIFLUOR C/G) is an in vitro direct immunofluorescent detection procedure for the simultaneous detection of Cryptosporidium oocysts and Giardia cysts in fecal material.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2025-11-03 | GET TESTED INTERNATIONAL AB | Distribution without premarket approval/clearance. |
| 2025-03-24 | MEDLINE INDUSTRIES, LP - Northfield | A single lot of the ImmunoCard STAT! Crypto/Giardia Test Kit was inadvertently stored in Medline warehouses at temperatures outside of the labeled storage requirements. |
| 2008-08-11 | Remel, Inc | Faint grey test lines for Cryptosporidium may be visible which may be interpreted as false positive |
| 2004-02-23 | Genzyme Diagnostics | False Positive results. |
| 2003-12-09 | Remel, Inc. | The conjugate may cause the negative control to produce high OD readings, therefore invalidating the run. |
| 2002-11-21 | Remel, Inc. | The conjugate of the ProSpecT Giardia/Cryptosporidium Microplate Assay, Lot #926230, may have become contaminated during filling. The particulates in the contamination may cause t |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.